Improved immunodiagnostic assays using reducing agents

Details for Australian Patent Application No. 2002301931 (hide)

Owner Innogenetics N.V.

Inventors Zrein, Maan; Sablon, Erwin; Bosman, Alfons; Louwagie, Joost; Maertens, Geert

Agent Davies Collison Cave

Pub. Number AU-B-2002301931

Parent 38171

Filing date 11 November 2002

Wipo publication date 13 March 2003

Acceptance publication date 6 January 2005

International Classifications

G01N 033/576 Investigating or analysing materials by specific methods not covered by groups - for hepatitis

G01N 033/569 Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 033/573 Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

C12Q 001/70 Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

C07K 014/18 Peptides having more than 20 amino acids

Event Publications

28 November 2002 Complete Application Filed

13 March 2003 Application Open to Public Inspection

  Published as AU-B-2002301931

6 January 2005 Application Accepted

  Published as AU-B-2002301931

5 May 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301932-Half ball valve

2002301930-Vaccine against lipopolysaccharide core